Mitsu Chem Plast

- Currently, there are no immediate plans for new capital expenditure (capex) or expansions. - The company has already completed expansions in the last one and a half years using a mix of debt and internal accruals. - A proposed Follow-on Public Offer (FPO) intended to raise capital is currently on hold. - The focus remains on utilizing existing capacities effectively rather than committing to fresh large-scale investments in the near term.

- Demand outlook is optimistic from Q4 FY23 and into FY24, with inquiries increasing significantly since January. - Growth is expected to be better than FY22 and FY23, driven by improving demand in India and export markets. - Expansion in chemical, pharmaceutical, agrochemical sectors is expected to boost growth. - Exports, especially in hospital furniture segment, show promise with growing inquiries but no current exports. - New client addition: 25-30 new clients added in last 6 months, mainly in plastic packaging. - Capacity utilization currently at around 65%, with scope for improvement as demand picks up. - Company is optimistic about entering sustainable packaging and recycling initiatives, which may spur future growth. - Expected sequential improvement in margins from Q4 due to normalization of polymer prices and better product mix. - Capital expenditure plans are on hold currently; expansion done in last 1.5 years funded through debt and internal accruals.

- The management is optimistic about FY24, expecting much better performance than FY22 and FY23. - Demand outlook from January 2023 is picking up strongly with increased inquiries converting into business. - Positive growth seen across sectors with better utilization expected in Q4 FY23 and beyond. - Repeat business is strong, with 80% revenue from about 50 clients, many being Fortune 500 companies, indicating stable earnings. - EBITDA margins expected to improve sequentially from Q4 FY23 as high-cost inventory gets exhausted. - Expansion plans on hold currently, but internal accruals and debt financing have supported past expansions. - Growth drivers include increasing demand in plastic packaging, hospital furniture, and new technical products. - Focus on sustainability and innovative products aims to enhance product mix and profitability. - Overall outlook for FY24 and FY25 is bullish with expected significant improvement in top-line and profitability.

- The company has added around 25 to 30 new clients in the last 6 months, indicating a growing order book. - Approximately 80% of the business comes from about 50 companies, with 45 to 50 companies providing repeat orders annually, showing a stable and recurring order flow. - Inquiry levels have picked up significantly from January, translating into many new inquiries and potential converts into business. - New orders are notably from plastic packaging, hospital furniture segments, and emerging export markets. - The company is optimistic about onboarding many more clients going forward. - No specific information on the total value or backlog of pending orders was disclosed, but improvement in inquiries and customer additions point to a positive order pipeline.

- Currently, there are no plans for new CAPEX or fundraising through debt or equity. - The company has recently expanded using debt and internal accruals. - There was a mention of a future Follow-on Public Offer (FPO), but it is currently on hold. - No additional debt or equity raising is planned at this moment.